Anti-bacterial	B:C0544570
and	I:C0544570
Anti-biofilm	I:C0544570
Evaluation	I:C0544570
of	O
Thiazolopyrimidinone	O
Derivatives	I:C1254351
Targeting	O
the	O
Histidine	O
Kinase	I:C0072399
YycG	O
Protein	I:C1870317
of	I:C1870317
Staphylococcus	I:C1870317
epidermidis	I:C1870317
Staphylococcus	O
epidermidis	I:C0038174
is	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
pathogens	O
in	O
nosocomial	O
infections	I:C0205721
.	O

Anti-bacterial	O
and	I:C0544570
Anti-biofilm	I:C0544570
Evaluation	I:C0544570
of	O
Thiazolopyrimidinone	B:C1254351
Derivatives	I:C1254351
Targeting	O
the	O
Histidine	O
Kinase	I:C0072399
YycG	O
Protein	I:C1870317
of	I:C1870317
Staphylococcus	I:C1870317
epidermidis	I:C1870317
Staphylococcus	O
epidermidis	I:C0038174
is	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
pathogens	O
in	O
nosocomial	O
infections	I:C0205721
.	O

Anti-bacterial	O
and	I:C0544570
Anti-biofilm	I:C0544570
Evaluation	I:C0544570
of	O
Thiazolopyrimidinone	O
Derivatives	I:C1254351
Targeting	O
the	O
Histidine	B:C0072399
Kinase	I:C0072399
YycG	O
Protein	I:C1870317
of	I:C1870317
Staphylococcus	I:C1870317
epidermidis	I:C1870317
Staphylococcus	O
epidermidis	I:C0038174
is	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
pathogens	O
in	O
nosocomial	O
infections	I:C0205721
.	O

Anti-bacterial	O
and	I:C0544570
Anti-biofilm	I:C0544570
Evaluation	I:C0544570
of	O
Thiazolopyrimidinone	O
Derivatives	I:C1254351
Targeting	O
the	O
Histidine	O
Kinase	I:C0072399
YycG	B:C1870317
Protein	I:C1870317
of	I:C1870317
Staphylococcus	I:C1870317
epidermidis	I:C1870317
Staphylococcus	O
epidermidis	I:C0038174
is	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
pathogens	O
in	O
nosocomial	O
infections	I:C0205721
.	O

Anti-bacterial	O
and	I:C0544570
Anti-biofilm	I:C0544570
Evaluation	I:C0544570
of	O
Thiazolopyrimidinone	O
Derivatives	I:C1254351
Targeting	O
the	O
Histidine	O
Kinase	I:C0072399
YycG	O
Protein	I:C1870317
of	I:C1870317
Staphylococcus	I:C1870317
epidermidis	I:C1870317
Staphylococcus	B:C0038174
epidermidis	I:C0038174
is	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
pathogens	O
in	O
nosocomial	O
infections	I:C0205721
.	O

Anti-bacterial	O
and	I:C0544570
Anti-biofilm	I:C0544570
Evaluation	I:C0544570
of	O
Thiazolopyrimidinone	O
Derivatives	I:C1254351
Targeting	O
the	O
Histidine	O
Kinase	I:C0072399
YycG	O
Protein	I:C1870317
of	I:C1870317
Staphylococcus	I:C1870317
epidermidis	I:C1870317
Staphylococcus	O
epidermidis	I:C0038174
is	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
pathogens	O
in	O
nosocomial	B:C0205721
infections	I:C0205721
.	O

The	O
main	O
pathogenicity	O
associated	O
with	O
S.	B:C0038174
epidermidis	I:C0038174
involves	O
the	O
formation	O
of	O
biofilms	O
on	O
implanted	O
medical	I:C2735362
devices	I:C2735362
,	O
biofilms	O
dramatically	O
decrease	O
the	O
efficacy	O
of	O
conventional	O
antibiotics	O
and	O
the	O
host	O
immune	O
system	I:C0020962
.	O

The	O
main	O
pathogenicity	O
associated	O
with	O
S.	O
epidermidis	I:C0038174
involves	O
the	O
formation	O
of	O
biofilms	B:C0081786
on	O
implanted	O
medical	I:C2735362
devices	I:C2735362
,	O
biofilms	O
dramatically	O
decrease	O
the	O
efficacy	O
of	O
conventional	O
antibiotics	O
and	O
the	O
host	O
immune	O
system	I:C0020962
.	O

The	O
main	O
pathogenicity	O
associated	O
with	O
S.	O
epidermidis	I:C0038174
involves	O
the	O
formation	O
of	O
biofilms	O
on	O
implanted	B:C2735362
medical	I:C2735362
devices	I:C2735362
,	O
biofilms	O
dramatically	O
decrease	O
the	O
efficacy	O
of	O
conventional	O
antibiotics	O
and	O
the	O
host	O
immune	O
system	I:C0020962
.	O

The	O
main	O
pathogenicity	O
associated	O
with	O
S.	O
epidermidis	I:C0038174
involves	O
the	O
formation	O
of	O
biofilms	O
on	O
implanted	O
medical	I:C2735362
devices	I:C2735362
,	O
biofilms	B:C0081786
dramatically	O
decrease	O
the	O
efficacy	O
of	O
conventional	O
antibiotics	O
and	O
the	O
host	O
immune	O
system	I:C0020962
.	O

The	O
main	O
pathogenicity	O
associated	O
with	O
S.	O
epidermidis	I:C0038174
involves	O
the	O
formation	O
of	O
biofilms	O
on	O
implanted	O
medical	I:C2735362
devices	I:C2735362
,	O
biofilms	O
dramatically	O
decrease	O
the	O
efficacy	O
of	O
conventional	O
antibiotics	B:C0003232
and	O
the	O
host	O
immune	O
system	I:C0020962
.	O

The	O
main	O
pathogenicity	O
associated	O
with	O
S.	O
epidermidis	I:C0038174
involves	O
the	O
formation	O
of	O
biofilms	O
on	O
implanted	O
medical	I:C2735362
devices	I:C2735362
,	O
biofilms	O
dramatically	O
decrease	O
the	O
efficacy	O
of	O
conventional	O
antibiotics	O
and	O
the	O
host	O
immune	B:C0020962
system	I:C0020962
.	O

This	O
emphasizes	O
the	O
urgent	O
need	O
for	O
designing	O
novel	O
anti-staphylococcal	B:C0279516
biofilm	I:C0279516
agents	I:C0279516
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	B:C1254351
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	B:C0072399
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	B:C1870317
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	B:C0544570
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	B:C0038174
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	B:C0243072
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	B:C0243072
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	B:C0373483
to	O
explore	O
their	O
anti-bacterial	O
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

Based	O
on	O
the	O
findings	O
that	O
compound	O
5	I:C1254351
,	O
targeting	O
the	O
histidine	O
kinase	I:C0072399
domain	I:C0072399
of	O
S.	O
epidermidis	I:C1870317
YycG	I:C1870317
,	O
possessed	O
bactericidal	O
activity	I:C0544570
against	O
staphylococci	O
,	O
39	O
derivatives	O
of	I:C0243072
compound	I:C0243072
5	I:C0243072
with	I:C0243072
intact	I:C0243072
thiazolopyrimidinone	I:C0243072
core	I:C0243072
structures	I:C0243072
were	O
newly	O
designed	O
,	O
7	O
derivatives	I:C0243072
were	O
further	O
screened	O
to	O
explore	O
their	O
anti-bacterial	B:C0544570
and	I:C0544570
anti-biofilm	I:C0544570
activities	I:C0544570
.	O

The	O
seven	B:C1254351
derivatives	I:C1254351
strongly	O
inhibited	O
the	I:C2244509
growth	I:C2244509
of	O
S.	O
epidermidis	I:C0038174
and	O
Staphylococcus	O
aureus	I:C0038172
in	O
the	O
minimal	O
inhibitory	I:C0427978
concentration	I:C0427978
range	O
of	O
1.56	O
-	O
6.25	O
μM	O
.	O

The	O
seven	O
derivatives	I:C1254351
strongly	O
inhibited	B:C2244509
the	I:C2244509
growth	I:C2244509
of	O
S.	O
epidermidis	I:C0038174
and	O
Staphylococcus	O
aureus	I:C0038172
in	O
the	O
minimal	O
inhibitory	I:C0427978
concentration	I:C0427978
range	O
of	O
1.56	O
-	O
6.25	O
μM	O
.	O

The	O
seven	O
derivatives	I:C1254351
strongly	O
inhibited	O
the	I:C2244509
growth	I:C2244509
of	O
S.	B:C0038174
epidermidis	I:C0038174
and	O
Staphylococcus	O
aureus	I:C0038172
in	O
the	O
minimal	O
inhibitory	I:C0427978
concentration	I:C0427978
range	O
of	O
1.56	O
-	O
6.25	O
μM	O
.	O

The	O
seven	O
derivatives	I:C1254351
strongly	O
inhibited	O
the	I:C2244509
growth	I:C2244509
of	O
S.	O
epidermidis	I:C0038174
and	O
Staphylococcus	B:C0038172
aureus	I:C0038172
in	O
the	O
minimal	O
inhibitory	I:C0427978
concentration	I:C0427978
range	O
of	O
1.56	O
-	O
6.25	O
μM	O
.	O

The	O
seven	O
derivatives	I:C1254351
strongly	O
inhibited	O
the	I:C2244509
growth	I:C2244509
of	O
S.	O
epidermidis	I:C0038174
and	O
Staphylococcus	O
aureus	I:C0038172
in	O
the	O
minimal	B:C0427978
inhibitory	I:C0427978
concentration	I:C0427978
range	O
of	O
1.56	O
-	O
6.25	O
μM	O
.	O

All	O
the	O
derivatives	B:C0243072
reduced	O
the	O
proportion	O
of	O
viable	O
cells	O
in	O
mature	O
biofilms	O
.	O

All	O
the	O
derivatives	O
reduced	O
the	O
proportion	O
of	O
viable	O
cells	O
in	O
mature	O
biofilms	B:C0081786
.	O

They	O
all	O
displayed	O
low	O
cytotoxicity	B:C0596402
on	O
mammalian	O
cells	I:C1512977
and	O
were	O
not	O
hemolytic	O
to	O
human	O
erythrocytes	O
.	O

They	O
all	O
displayed	O
low	O
cytotoxicity	O
on	O
mammalian	B:C1512977
cells	I:C1512977
and	O
were	O
not	O
hemolytic	O
to	O
human	O
erythrocytes	O
.	O

They	O
all	O
displayed	O
low	O
cytotoxicity	O
on	O
mammalian	O
cells	I:C1512977
and	O
were	O
not	O
hemolytic	B:C2945560
to	O
human	O
erythrocytes	O
.	O

They	O
all	O
displayed	O
low	O
cytotoxicity	O
on	O
mammalian	O
cells	I:C1512977
and	O
were	O
not	O
hemolytic	O
to	O
human	B:C0086418
erythrocytes	O
.	O

They	O
all	O
displayed	O
low	O
cytotoxicity	O
on	O
mammalian	O
cells	I:C1512977
and	O
were	O
not	O
hemolytic	O
to	O
human	O
erythrocytes	B:C0014792
.	O

The	O
biofilm	B:C0081786
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	B:C0243072
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	B:C1254351
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	B:C1254351
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	B:C1254351
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	B:C1254351
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	B:C0081786
formation	O
of	O
S.	O
epidermidis	I:C0038174
.	O

The	O
biofilm	O
inhibition	O
activities	O
of	O
four	O
derivatives	O
(	O
H5	O
-	I:C1254351
32	I:C1254351
,	O
H5	O
-	I:C1254351
33	I:C1254351
,	O
H5	O
-	I:C1254351
34	I:C1254351
,	O
and	O
H5	O
-	I:C1254351
35	I:C1254351
)	O
were	O
further	O
investigated	O
under	O
shearing	O
forces	O
,	O
they	O
all	O
led	O
to	O
significant	O
decreases	O
in	O
the	O
biofilm	O
formation	O
of	O
S.	B:C0038174
epidermidis	I:C0038174
.	O

These	O
results	O
were	O
suggestive	O
that	O
the	O
seven	B:C1254351
derivatives	I:C1254351
of	I:C1254351
compound	I:C1254351
5	I:C1254351
have	O
the	O
potential	O
to	O
be	O
developed	O
into	O
agents	O
for	O
eradicating	O
biofilm	O
-	O
associated	O
infections	O
.	O

These	O
results	O
were	O
suggestive	O
that	O
the	O
seven	O
derivatives	I:C1254351
of	I:C1254351
compound	I:C1254351
5	I:C1254351
have	O
the	O
potential	O
to	O
be	O
developed	O
into	O
agents	O
for	O
eradicating	O
biofilm	B:C0081786
-	O
associated	O
infections	O
.	O

These	O
results	O
were	O
suggestive	O
that	O
the	O
seven	O
derivatives	I:C1254351
of	I:C1254351
compound	I:C1254351
5	I:C1254351
have	O
the	O
potential	O
to	O
be	O
developed	O
into	O
agents	O
for	O
eradicating	O
biofilm	O
-	O
associated	O
infections	B:C3714514
.	O

